Zensar Technologies (504067) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jul, 2026Executive summary
Q3 FY25 revenue reached $157.0M, up 0.5% sequentially and 8.6% year-over-year, marking one of the best Q3 performances in recent years.
EBITDA margin stood at 15.6%, improving by 20 bps quarter-over-quarter, with PAT margin at 12%.
Order book hit a record $205.3M, with broad-based contributions and no large deals included.
Cash and cash equivalents at quarter-end were $269.2M, up $14.2M from the previous quarter.
Interim dividend of INR 2 per share declared, payable to shareholders as of January 28, 2025.
Financial highlights
Q3 FY25 revenue: $157.0M, up 0.5% QoQ and 8.6% YoY in reported currency.
Gross margin: 30.1%, up 200 bps QoQ due to improved utilization and operational efficiencies.
EBITDA margin: 15.6%, up 20 bps QoQ; PAT margin: 12%.
Cash reserves increased to $269.2M, a $14.2M QoQ rise; DSO improved by 3 days to 68 days.
Consolidated revenue from operations for Q3 FY25 was ₹13,256 million, up from ₹12,041 million in Q3 FY24.
Outlook and guidance
Pipeline remains healthy, with strong order bookings for two consecutive quarters above $200M.
Targeting double-digit growth for FY26, with continued focus on margin improvement and annuity revenues.
Mid-teens EBITDA margin guidance maintained, with ongoing investments in business growth.
Continued focus on cloud, infrastructure, and AI-driven solutions for clients.
Interim dividend declared for FY25, with record date set for January 28, 2025.
Latest events from Zensar Technologies
- Q1 FY27 revenue up to $159.5M, EBITDA margin down, BFSI and AI drive growth, cash strong.504067
Q1 26/2730 Jul 2026 - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/268 Jul 2026 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/258 Jul 2026 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/2519 Jun 2026 - Q1 FY26 revenue up 4.9% YoY to $162M, with strong AI and digital/cloud growth but margin pressures.504067
Q1 25/2619 Jun 2026 - AI-driven growth, robust financials, and ESG leadership marked FY26 performance.504067
Investor presentation26 May 2026 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/2623 Jan 2026 - Q2 revenue up 4.2% YoY to $162.8M, with margin gains, AI momentum, and TMT headwinds.504067
Q2 25/262 Nov 2025